Analyst Confidence Soars for 89bio Despite Lengthy Clinical Pathway
While 89bio continues to advance its key Phase 3 trial for its flagship drug candidate, Pegozafermin, the company has received...
My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers.
My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world.
A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses.
In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.
While 89bio continues to advance its key Phase 3 trial for its flagship drug candidate, Pegozafermin, the company has received...
Microsoft Corporation's stock experienced notable volatility on Friday following the disclosure that Chief Executive Officer Satya Nadella had liquidated a...
Marvell Technology delivered what appeared to be a stellar earnings report, yet investors responded with a sell-off that sent shares...
A powerful rally among major US technology companies is serving as the primary catalyst for the iShares MSCI World ETF's...
A pivotal antitrust court decision involving Google has unexpectedly secured a multi-billion dollar revenue stream for Apple, providing a significant...
BioNTech SE has achieved a significant milestone in its oncology pipeline, sending its stock price sharply higher. The Mainz-based biotechnology...
Uranium Energy Corp (UEC) has surged to a historic peak, with its shares reaching an unprecedented $11.40. This milestone represents...
Lucid Group's stock experienced a dramatic reversal on Friday, surging 13.83% to close at $18.40. This powerful rally snapped a...
While numerous regional financial institutions face headwinds from the current interest rate environment, Washington Federal Bank (WaFd) continues its commitment...
Advanced Micro Devices (AMD) finds itself at a critical juncture as confidence in its artificial intelligence growth strategy shows signs...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com